{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:29:50Z","timestamp":1793741390030,"version":"4.6.1"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:00:00Z","timestamp":1793664000000},"content-version":"vor","delay-in-days":216,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["2026"],"award-info":[{"award-number":["2026"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["PNRR-POC-2023-12377653"],"award-info":[{"award-number":["PNRR-POC-2023-12377653"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jns.2026.125835","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:51:20Z","timestamp":1771951880000},"page":"125835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Workshop report: Findings from the 2025 Italian SMAkers Educational Initiative on SMA management in Italy"],"prefix":"10.1016","volume":"483","author":[{"given":"Stefania","family":"Corti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Gadaleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Bitetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Crescimanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"D'Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Dosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata Katia","family":"Patanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carmela","family":"Pera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Risi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Roma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sframeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Coratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Pane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria A.","family":"Sansone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2026.125835_bb0005","doi-asserted-by":"crossref","first-page":"e1634","DOI":"10.1212\/WNL.0000000000009248","article-title":"Population-based analysis of survival in spinal muscular atrophy","volume":"94","author":"Wijngaarde","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2026.125835_bb0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.jns.2026.125835_bb0015","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41582-020-00413-4","article-title":"Spinal muscular atrophy - insights and challenges in the treatment era","volume":"16","author":"Mercuri","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-022-00380-8","article-title":"Spinal muscular atrophy","volume":"8","author":"Mercuri","year":"2022","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.jns.2026.125835_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s12887-022-03671-x","article-title":"Advances and limitations for the treatment of spinal muscular atrophy","volume":"22","author":"Day","year":"2022","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.jns.2026.125835_bb0030","series-title":"GeneReviews [Internet]","article-title":"Spinal muscular atrophy","author":"Kolb","year":"1993"},{"key":"10.1016\/j.jns.2026.125835_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2025.105341","article-title":"Assessing disease progression in spinal muscular atrophy, current gaps, and opportunities: a narrative review","volume":"49","author":"Muni-Lofra","year":"2025","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0040","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.nmd.2018.01.003","article-title":"Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases","volume":"28","author":"Calucho","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0045","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","article-title":"Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice","volume":"82","author":"Hua","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jns.2026.125835_bb0050","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nrneurol.2015.77","article-title":"Spinal muscular atrophy - recent therapeutic advances for an old challenge","volume":"11","author":"Faravelli","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0055","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2026.125835_bb0060","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.nmd.2024.01.005","article-title":"Effect of nusinersen treatment on quality of life and motor function in adult patients with spinal muscular atrophy","volume":"36","author":"\u015eim\u015fek Erdem","year":"2024","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0065","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2026.125835_bb0070","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2102047","article-title":"Risdiplam-treated infants with type 1 spinal muscular atrophy versus historical controls","volume":"385","author":"Darras","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2026.125835_bb0075","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00018-015-2106-9","article-title":"Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?","volume":"73","author":"Simone","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jns.2026.125835_bb0080","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-021-01783-8","article-title":"Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years","volume":"16","author":"Vill","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0085","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.nmd.2021.03.007","article-title":"Newborn screening programs for spinal muscular atrophy worldwide: where we stand and where to go","volume":"31","author":"Dangouloff","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0090","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1177\/22143602241288095","article-title":"Newborn screening programs for spinal muscular atrophy worldwide in 2023","volume":"11","author":"Vr\u0161\u010daj","year":"2024","journal-title":"J. Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijns7010020","article-title":"A voluntary statewide newborn screening pilot for spinal muscular atrophy: results from early check","volume":"7","author":"Kucera","year":"2021","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.jns.2026.125835_bb0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3233\/JND-221577","article-title":"Newborn screening SMA - from pilot project to nationwide screening in Germany","volume":"10","author":"M\u00fcller-Felber","year":"2023","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0105","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/jmg-2022-108873","article-title":"Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific guidelines and standard operating procedures for the molecular diagnosis","volume":"60","author":"Abiusi","year":"2023","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.jns.2026.125835_bb0110","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.nmd.2021.03.012","article-title":"Age related treatment effect in type II spinal muscular atrophy pediatric patients treated with nusinersen","volume":"31","author":"Coratti","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0115","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s40120-024-00653-2","article-title":"Effectiveness of nusinersen in adolescents and adults with spinal muscular atrophy: systematic review and meta-analysis","volume":"13","author":"Hagenacker","year":"2024","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.jns.2026.125835_bb0120","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1212\/CPJ.0000000000001033","article-title":"Nusinersen treatment in adults with spinal muscular atrophy","volume":"11","author":"Duong","year":"2021","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.jns.2026.125835_bb0125","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1111\/ene.15501","article-title":"Nusinersen in adult patients with 5q spinal muscular atrophy: a multicenter observational cohorts\u2019 study","volume":"29","author":"V\u00e1zquez-Costa","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0130","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-020-1339-3","article-title":"Health, wellbeing and lived experiences of adults with SMA: a scoping systematic review","volume":"15","author":"Wan","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0135","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","article-title":"Diagnosis and management of spinal muscular atrophy: part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics","volume":"28","author":"Finkel","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0145","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.nmd.2019.10.001","article-title":"A critical review of patient and parent caregiver oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in spinal muscular atrophy","volume":"29","author":"Messina","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0150","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.nmd.2023.03.011","article-title":"Formation of a European network to initiate a European data collection, along with development and sharing of treatment guidelines for adult SMA patients. Virtual meeting 28-30 January 2022","volume":"33","author":"Walter","year":"2023","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0155","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nmd.2024.02.003","article-title":"Bulbar function in spinal muscular atrophy (SMA): state of art and new challenges. 21st July 2023, Rome, Italy","volume":"38","author":"McGrattan","year":"2024","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0160","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200374","article-title":"Spinal muscular atrophy update in best practices: recommendations for treatment considerations","volume":"15","author":"Schroth","year":"2025","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.jns.2026.125835_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2025.105278","article-title":"Italian survey on evolving SMA care with disease-modifying therapies: a workshop on nutrition, swallowing, respiratory and rehabilitation care","volume":"48","author":"Corti","year":"2025","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0170","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/acn3.52018","article-title":"Early spinal muscular atrophy treatment following newborn screening: a 20-month review of the first Italian regional experience","volume":"11","author":"Gagliardi","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"suppl.","key":"10.1016\/j.jns.2026.125835_bb0175","first-page":"4","article-title":"Legge Regionale 19 aprile 2021, n. 4. Screening obbligatorio per l\u2019atrofia muscolare spinale","volume":"57","author":"Regione Puglia","year":"2021","journal-title":"Bollettino Ufficiale della Regione Puglia"},{"key":"10.1016\/j.jns.2026.125835_bb0180","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.nmd.2023.12.008","article-title":"270th ENMC International Workshop: consensus for SMN2 genetic analysis in SMA patients 10-12 March, 2023, Hoofddorp, the Netherlands","volume":"34","author":"Abiusi","year":"2024","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0185","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/dmcn.15117","article-title":"Integrating newborn screening for spinal muscular atrophy into health care systems: an Australian pilot programme","volume":"64","author":"D\u2019Silva","year":"2022","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0190","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99496-2","article-title":"Three years pilot of spinal muscular atrophy newborn screening turned into official program in southern Belgium","volume":"11","author":"Boemer","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2026.125835_bb0195","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jns.2015.08.1532","article-title":"Quantitative muscle ultrasound measures rapid declines over time in children with SMA type 1","volume":"358","author":"Ng","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2026.125835_bb0200","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/ijns10030058","article-title":"Newborn screening for spinal muscular atrophy: variations in practice and early management of infants with spinal muscular atrophy in the United States","volume":"10","author":"Zaidman","year":"2024","journal-title":"Int. J. Neonatal Screen."},{"key":"10.1016\/j.jns.2026.125835_bb0205","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.20473","article-title":"Natural history of denervation in SMA: relation to age, SMN2 copy number, and function","volume":"57","author":"Swoboda","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0210","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41436-020-00987-w","article-title":"CMAP changes upon symptom onset and during treatment in spinal muscular atrophy patients: lessons learned from newborn screening","volume":"23","author":"Weng","year":"2021","journal-title":"Genet. Med."},{"key":"10.1016\/j.jns.2026.125835_bb0215","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/mus.10050","article-title":"Motor unit number estimation in infants and children with spinal muscular atrophy","volume":"25","author":"Bromberg","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2026.125835_bb0220","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41436-019-0673-0","article-title":"The implementation of newborn screening for spinal muscular atrophy: the Australian experience","volume":"22","author":"Kariyawasam","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.jns.2026.125835_bb0225","series-title":"Letter of support for drug development for neurofilament light (NfL) as a biomarker to monitor disease activity in patients with spinal muscular atrophy (SMA). EMA\/CHMP\/SAWP\/545591\/2022","author":"European Medicines Agency (EMA)","year":"2022"},{"key":"10.1016\/j.jns.2026.125835_bb0230","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/acn3.779","article-title":"Neurofilament as a potential biomarker for spinal muscular atrophy","volume":"6","author":"Darras","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0235","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/acn3.51449","article-title":"Serum neurofilament light chain in pediatric spinal muscular atrophy patients and healthy children","volume":"8","author":"Nitz","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0240","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1111\/jcmm.14939","article-title":"Nusinersen treatment and cerebrospinal fluid neurofilaments: an explorative study on spinal muscular atrophy type 3 patients","volume":"24","author":"Faravelli","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jns.2026.125835_bb0245","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1515\/cclm-2023-1311","article-title":"Neurofilament light protein as a biomarker for spinal muscular atrophy: a review and reference ranges","volume":"62","author":"Bayoumy","year":"2024","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jns.2026.125835_bb0250","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/acn3.51276","article-title":"Type I SMA \u201cnew natural history\u201d: long-term data in nusinersen-treated patients","volume":"8","author":"Pane","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0255","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1007\/s00431-022-04470-3","article-title":"Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screening","volume":"181","author":"Pane","year":"2022","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.jns.2026.125835_bb0260","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.chest.2023.03.011","article-title":"Respiratory management of patients with neuromuscular weakness: an American College of Chest Physicians Clinical Practice Guideline and Expert Panel Report","volume":"164","author":"Khan","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.jns.2026.125835_bb0265","series-title":"Newborn Screening Implementation Consortium (NBSIC) Policy Guidance","author":"U.S. Health Resources & Services Administration (HRSA)","year":"2024"},{"key":"10.1016\/j.jns.2026.125835_bb0270","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.nmd.2007.05.009","article-title":"An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients","volume":"17","author":"O\u2019Hagen","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0275","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12883-017-0790-9","article-title":"Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy","volume":"17","author":"Pera","year":"2017","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172346","article-title":"Revised Hammersmith Scale for spinal muscular atrophy: a SMA specific clinical outcome assessment tool","volume":"12","author":"Ramsey","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jns.2026.125835_bb0285","article-title":"Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded (HFMSE) for untreated spinal muscular atrophy patients: an international study","volume":"31","author":"Coratti","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0290","series-title":"Cure SMA Foundation Report","article-title":"Standardization of functional outcome assessments in SMA clinical practice","author":"Cure SMA Clinical Evaluators Best Practices","year":"2021"},{"key":"10.1016\/j.jns.2026.125835_bb0295","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/mus.26419","article-title":"Revised upper limb module for spinal muscular atrophy: 12 month changes","volume":"59","author":"Pera","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2026.125835_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12103458","article-title":"Measuring fatigue and fatigability in spinal muscular atrophy (SMA): challenges and opportunities","volume":"12","author":"Rodriguez-Torres","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jns.2026.125835_bb0305","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JND-180342","article-title":"Perceived fatigue in spinal muscular atrophy: a pilot study","volume":"6","author":"Dunaway Young","year":"2019","journal-title":"J. Neuromuscul. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2026.125835_bb0310","article-title":"Longitudinal assessment of the Adapted Test for Neuromuscular Disease (ATEND) in individuals living with spinal muscular atrophy (SMA)","volume":"43","author":"Duong","year":"2024","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0315","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jns.2026.125835_bb0320","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.nmd.2020.06.009","article-title":"Utility of maximum inspiratory and expiratory pressures as a screening method for respiratory insufficiency in slowly progressive neuromuscular disorders","volume":"30","author":"Wenninger","year":"2020","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0325","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01214-2018","article-title":"ERS statement on respiratory muscle testing at rest and during exercise","volume":"53","author":"Laveneziana","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jns.2026.125835_bb0330","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200298","article-title":"Therapeutic role of nusinersen on respiratory progression in pediatric patients with spinal muscular atrophy type 2 and nonambulant type 3","volume":"14","author":"Trucco","year":"2024","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.jns.2026.125835_bb0335","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.14222","article-title":"Spectrum of sleep-disordered breathing and quality of sleep in adolescent and adult patients with spinal muscular atrophy","volume":"33","author":"Crescimanno","year":"2024","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.jns.2026.125835_bb0340","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/apmr.2001.18053","article-title":"Supine fall in lung volumes in the assessment of diaphragmatic weakness in neuromuscular disorders","volume":"82","author":"Fromageot","year":"2001","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.jns.2026.125835_bb0345","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1378\/chest.121.2.436","article-title":"Spirometry in the supine position improves the detection of diaphragmatic weakness in patients with amyotrophic lateral sclerosis","volume":"121","author":"Lechtzin","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.jns.2026.125835_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106740","article-title":"The use of cough peak flow in the assessment of respiratory function in clinical practice - a narrative literature review","volume":"193","author":"Brennan","year":"2022","journal-title":"Respir. Med."},{"key":"10.1016\/j.jns.2026.125835_bb0355","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3233\/JND-200617","article-title":"A Canadian adult spinal muscular atrophy outcome measures toolkit: results of a national consensus using a modified Delphi method","volume":"8","author":"Slayter","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0360","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1164\/ajrccm.159.1.9804052","article-title":"Sniff nasal inspiratory pressure. Reference values in Caucasian children","volume":"159","author":"Stefanutti","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jns.2026.125835_bb0365","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/ana.410090515","article-title":"Preservation of the phrenic motoneurons in Werdnig-Hoffmann disease","volume":"9","author":"Kuzuhara","year":"1981","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0370","doi-asserted-by":"crossref","first-page":"e587","DOI":"10.1212\/WNL.0000000000011051","article-title":"Respiratory trajectories in type 2 and 3 spinal muscular atrophy in the iSMAC cohort study","volume":"96","author":"Trucco","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2026.125835_bb0375","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ultrasmedbio.2004.05.013","article-title":"Muscle ultrasound in children: normal values and application to neuromuscular disorders","volume":"30","author":"Maurits","year":"2004","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.jns.2026.125835_bb0380","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/000348941312201109","article-title":"Reliability and validity of the Italian Eating Assessment Tool","volume":"122","author":"Schindler","year":"2013","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"10.1016\/j.jns.2026.125835_bb0385","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00405-022-07685-0","article-title":"Flexible endoscopic evaluation of swallowing in children with type 1 spinal muscular atrophy","volume":"280","author":"Zang","year":"2023","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.jns.2026.125835_bb0390","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/joor.12728","article-title":"International standardisation of the test of masticating and swallowing solids in children","volume":"46","author":"Frank","year":"2019","journal-title":"J. Oral Rehabil."},{"key":"10.1016\/j.jns.2026.125835_bb0395","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/1460-6984.12450","article-title":"Quantitative assessment of oral phase efficiency: validation of the Test of Masticating and Swallowing Solids (TOMASS)","volume":"54","author":"Lamvik-Gozdzikowska","year":"2019","journal-title":"Int. J. Lang. Commun. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2021.106958","article-title":"The Test of Masticating and Swallowing Solids (TOMASS): normative data for the adult Indian population","volume":"35","author":"Krishnamurthy","year":"2021","journal-title":"Data Brief"},{"key":"10.1016\/j.jns.2026.125835_bb0405","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-023-02688-4","article-title":"Objective measurement of oral function in adults with spinal muscular atrophy","volume":"18","author":"Kruse","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0410","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s00455-021-10369-2","article-title":"Cross-cultural adaptation and validation of the Italian version of the dysphagia handicap index (I-DHI)","volume":"37","author":"Ginocchio","year":"2022","journal-title":"Dysphagia"},{"key":"10.1016\/j.jns.2026.125835_bb0415","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3233\/JND-190379","article-title":"Bulbar problems self-reported by children and adults with spinal muscular atrophy","volume":"6","author":"van der Heul","year":"2019","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0420","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3233\/JND-240007","article-title":"Natural history of mandibular function in spinal muscular atrophy types 2 and 3","volume":"11","author":"van Bruggen","year":"2024","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0425","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213839","article-title":"Spinal muscular atrophy functional composite score revised (SMA-FCR) in untreated and nusinersen-treated patient cohorts","volume":"105","author":"Pasternak","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2026.125835_bb0430","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.clinph.2020.11.044","article-title":"Motor unit reserve capacity in spinal muscular atrophy during fatiguing endurance performance","volume":"132","author":"Habets","year":"2021","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jns.2026.125835_bb0435","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-020-1348-2","article-title":"Fatigability in spinal muscular atrophy: validity and reliability of endurance shuttle tests","volume":"15","author":"Bartels","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0440","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s00415-020-10227-5","article-title":"An observational cohort study on impact, dimensions and outcome of perceived fatigue in adult 5q-spinal muscular atrophy patients receiving nusinersen treatment","volume":"268","author":"Binz","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0445","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s40120-023-00552-y","article-title":"Evaluating perceived fatigue within an adult spinal muscular atrophy population","volume":"12","author":"Belter","year":"2023","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.jns.2026.125835_bb0450","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/sleep\/31.11.1601","article-title":"Validation of the fatigue severity scale in a Swiss cohort","volume":"31","author":"Valko","year":"2008","journal-title":"Sleep"},{"key":"10.1016\/j.jns.2026.125835_bb0455","article-title":"Screening cut-off scores for clinically significant fatigue in early Parkinson\u2019s disease","volume":"9","author":"Huether","year":"2023","journal-title":"Clin. Park. Relat. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0460","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1468-1331.2010.02992.x","article-title":"Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases","volume":"17","author":"Sansone","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0465","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1212\/WNL.0b013e3181d3e308","article-title":"Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy","volume":"74","author":"Montes","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2026.125835_bb0470","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/mus.26633","article-title":"Nusinersen improves walking distance and reduces fatigue in later-onset spinal muscular atrophy","volume":"60","author":"Montes","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2026.125835_bb0475","first-page":"816","article-title":"Six-minute walk test as outcome measure of fatigability in adults with spinal muscular atrophy treated with nusinersen","volume":"70","author":"Govoni","year":"2024","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2026.125835_bb0480","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.nmd.2017.01.018","article-title":"Disease impact on general well-being and therapeutic expectations of European type II and type III spinal muscular atrophy patients","volume":"27","author":"Rouault","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0485","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1007\/s00415-020-10332-5","article-title":"Development of new outcome measures for adult SMA type III and IV: a multimodal longitudinal study","volume":"268","author":"Querin","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0490","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1007\/s00415-020-09847-8","article-title":"Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy","volume":"267","author":"Osmanovic","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.120059","article-title":"Development of the SMA independence scale-upper limb module (SMAIS-ULM): a novel scale for individuals with type 2 and non-ambulant type 3 SMA","volume":"432","author":"Trundell","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2026.125835_bb0500","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00431-025-06207-4","article-title":"Italian validation of the SMA independence scale-upper limb module","volume":"184","author":"Bravetti","year":"2025","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.jns.2026.125835_bb0505","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mus.27223","article-title":"The Spinal Muscular Atrophy Health Index: a novel outcome for measuring how a patient feels and functions","volume":"63","author":"Zizzi","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2026.125835_bb0510","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.nmd.2021.02.006","article-title":"The Spinal Muscular Atrophy Health Index: Italian validation of a disease-specific outcome measure","volume":"31","author":"Sansone","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0515","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/mus.27644","article-title":"Assessing perspectives of disease burden and clinically meaningful changes using the Spinal Muscular Atrophy Health Index in adolescents and young adults","volume":"66","author":"Mazzella","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2026.125835_bb0520","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3233\/JND-221595","article-title":"Patient reported outcome measures in adult spinal muscular atrophy: a scoping review and graphical visualization of the evidence","volume":"10","author":"Slayter","year":"2023","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0525","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.jns.2026.125835_bb0530","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jns.2026.125835_bb0535","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MLR.0b013e318160d093","article-title":"Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population","volume":"46","author":"L\u00f6we","year":"2008","journal-title":"Med. Care"},{"key":"10.1016\/j.jns.2026.125835_bb0540","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-020-01661-9","article-title":"Executive function is inversely correlated with physical function: the cognitive profile of adult Spinal Muscular Atrophy (SMA)","volume":"16","author":"Mix","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0545","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12883-023-03261-z","article-title":"Cognitive performance of adult patients with SMA before and after treatment initiation with nusinersen","volume":"23","author":"Vidovic","year":"2023","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0550","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/joa.12083","article-title":"Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?","volume":"224","author":"Shababi","year":"2014","journal-title":"J. Anat."},{"key":"10.1016\/j.jns.2026.125835_bb0555","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11091184","article-title":"Cognitive impairment in adult patients with 5q-associated spinal muscular atrophy","volume":"11","author":"Kizina","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.jns.2026.125835_bb0560","doi-asserted-by":"crossref","DOI":"10.1186\/s11689-021-09355-4","article-title":"Intellectual abilities, language comprehension, speech, and motor function in children with spinal muscular atrophy type 1","volume":"13","author":"Zappa","year":"2021","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0565","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2024.1407341","article-title":"Cognitive impairment in children with 5q-associated spinal muscular atrophy type 1: two case reports and the review of the literature","volume":"12","author":"Yang","year":"2024","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.jns.2026.125835_bb0570","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2021.631668","article-title":"Revised short screening version of the Profile of Mood States (POMS) from the German general population","volume":"12","author":"Petrowski","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jns.2026.125835_bb0575","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.812063","article-title":"Assessment of health-related quality of life in adult spinal muscular atrophy under nusinersen treatment - a pilot study","volume":"12","author":"Thimm","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0580","doi-asserted-by":"crossref","first-page":"e1241","DOI":"10.1212\/WNL.0000000000008166","article-title":"Long-term progression in type II spinal muscular atrophy: a retrospective observational study","volume":"93","author":"Mercuri","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2026.125835_bb0585","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2025.1542396","article-title":"Spinal muscular atrophy in the era of newborn screening: how the classification could change","volume":"16","author":"Varone","year":"2025","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0590","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/ana.26788","article-title":"Clinical phenotype of pediatric and adult patients with spinal muscular atrophy with four SMN2 copies: are they really all stable?","volume":"94","author":"Ricci","year":"2023","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0595","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.27853","article-title":"Continued benefit of nusinersen initiated in the presymptomatic stage of spinal muscular atrophy: 5-year update of the NURTURE study","volume":"68","author":"Crawford","year":"2023","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2026.125835_bb0600","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41591-022-01867-3","article-title":"Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the phase III SPR1NT trial","volume":"28","author":"Strauss","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.jns.2026.125835_bb0605","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1242\/dmm.030148","article-title":"Therapeutic strategies for spinal muscular atrophy: SMN and beyond","volume":"10","author":"Bowerman","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.jns.2026.125835_bb0610","article-title":"Spinal muscular atrophy: from approved therapies to future therapeutic targets for personalized medicine","volume":"2","author":"Chaytow","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.jns.2026.125835_bb0615","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/JND-200551","article-title":"Real-world data from nusinersen treatment for patients with later-onset spinal muscular atrophy: a single center experience","volume":"8","author":"Mendon\u00e7a","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0620","article-title":"Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study","volume":"39","author":"G\u00fcnther","year":"2024","journal-title":"Lancet Reg. Health Eur."},{"key":"10.1016\/j.jns.2026.125835_bb0625","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/mus.27034","article-title":"Combination molecular therapies for type 1 spinal muscular atrophy","volume":"62","author":"Harada","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2026.125835_bb0630","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/ajmg.a.38220","article-title":"Newborn screening for spinal muscular atrophy: the views of affected families and adults","volume":"173","author":"Boardman","year":"2017","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.jns.2026.125835_bb0635","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192416935","article-title":"Communication of the diagnosis of spinal muscular atrophy in the views of patients and family members, a qualitative analysis","volume":"19","author":"Fernandes","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.jns.2026.125835_bb0640","article-title":"The diagnosis communication process in spinal muscular atrophy: a cross-cutting view of the new challenges facing the therapeutic era","volume":"1","author":"Rovira-Moreno","year":"2023","journal-title":"Genet. Med. Open"},{"key":"10.1016\/j.jns.2026.125835_bb0645","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1111\/ene.14472","article-title":"Minimal clinically important differences in functional motor scores in adults with spinal muscular atrophy","volume":"27","author":"Stolte","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0650","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3233\/JND-200534","article-title":"Measuring outcomes in adults with spinal muscular atrophy - challenges and future directions - meeting report","volume":"7","author":"Sansone","year":"2020","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0655","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3233\/JND-230211","article-title":"Disease trajectories in the revised hammersmith scale in a cohort of untreated patients with spinal muscular atrophy types 2 and 3","volume":"11","author":"Wolfe","year":"2024","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0660","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13216306","article-title":"The impact of nusinersen treatment on respiratory function in patients with spinal muscular atrophy: a systematic review","volume":"13","author":"Aldukain","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jns.2026.125835_bb0665","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1177\/22143602251336076","article-title":"Thinking outside the box: a re-evaluation of Canadian recommended outcome measures in adult spinal muscular atrophy - report of a national workshop","volume":"12","author":"O\u2019Connell","year":"2025","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0670","doi-asserted-by":"crossref","first-page":"6478","DOI":"10.1038\/s41598-025-91276-6","article-title":"Multiple respiratory assessment and thresholds for noninvasive ventilation in adult patients with spinal muscular atrophy","volume":"15","author":"Crescimanno","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2026.125835_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105488","article-title":"Dual SMN inducing therapies can rescue survival and motor unit function in symptomatic \u03947SMA mice","volume":"159","author":"Kray","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0680","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/mus.27375","article-title":"Combination therapy with onasemnogene and risdiplam in spinal muscular atrophy type 1","volume":"64","author":"Oechsel","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2026.125835_bb0685","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.omtm.2021.10.011","article-title":"Implications of circulating neurofilaments for spinal muscular atrophy treatment early in life: a case series","volume":"23","author":"Alves","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jns.2026.125835_bb0690","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3233\/JND-210735","article-title":"Neurofilament levels in CSF and serum in an adult SMA cohort treated with nusinersen","volume":"9","author":"Rich","year":"2022","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0695","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3233\/JND-230054","article-title":"Identifying biomarkers of spinal muscular atrophy for further development","volume":"10","author":"Glascock","year":"2023","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0700","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa075","article-title":"Intragenic and structural variation in the SMN locus and clinical variability in spinal muscular atrophy","volume":"2","author":"Wadman","year":"2020","journal-title":"Brain Commun."},{"key":"10.1016\/j.jns.2026.125835_bb0705","article-title":"Systematic review of presymptomatic treatment for spinal muscular atrophy","volume":"10","author":"Cooper","year":"2024","journal-title":"Int. J. Neonatal. Screen."},{"key":"10.1016\/j.jns.2026.125835_bb0710","article-title":"Use of telemedicine healthcare systems in children and adolescents with chronic disease or in transition stages of life: consensus document","volume":"13","author":"Esposito","year":"2023","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.jns.2026.125835_bb0715","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/22143602241313113","article-title":"A state-of-the-art review of registries in spinal muscular atrophy: a valuable resource for clinical research","volume":"12","author":"Balaji","year":"2025","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0720","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/JND-180304","article-title":"Treatment algorithm for infants diagnosed with spinal muscular atrophy through newborn screening","volume":"5","author":"Glascock","year":"2018","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0725","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3233\/JND-190468","article-title":"Revised recommendations for the treatment of infants diagnosed with spinal muscular atrophy via newborn screening who have 4 copies of SMN2","volume":"7","author":"Glascock","year":"2020","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0730","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.nmd.2019.09.007","article-title":"Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: interim efficacy and safety results from the phase 2 NURTURE study","volume":"29","author":"De Vivo","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jns.2026.125835_bb0735","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejpn.2024.08.006","article-title":"Outcomes for patients in the RESTORE registry with spinal muscular atrophy and four or more SMN2 gene copies treated with onasemnogene abeparvovec","volume":"53","author":"Tizzano","year":"2024","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0740","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-017-0598-0","article-title":"Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature","volume":"12","author":"Schoser","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0745","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1372674","article-title":"Respiratory function in adult patients with spinal muscular atrophy treated with nusinersen - a monocenter observational study","volume":"15","author":"Wurster","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2026.125835_bb0750","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-025-04009-3","article-title":"Respiratory function in 192 adult patients with spinal muscular atrophy (SMA) treated with nusinersen - a multicenter observational study","volume":"20","author":"Wurster","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2026.125835_bb0755","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/mus.27938","article-title":"Impaired diaphragmatic motility in treatment-naive adult patients with spinal muscular atrophy improved during nusinersen treatment","volume":"68","author":"Freigang","year":"2023","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2026.125835_bb0760","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200222","article-title":"Spectrum of phenotypes in SMA patients with 4 SMN2 copies in the French population: registre SMA France","volume":"11","author":"Gerin","year":"2025","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.jns.2026.125835_bb0765","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamapediatrics.2024.0492","article-title":"Clinical effectiveness of newborn screening for spinal muscular atrophy: a nonrandomized controlled trial","volume":"178","author":"Schwartz","year":"2024","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.jns.2026.125835_bb0770","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s00415-024-12188-5","article-title":"5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2","volume":"271","author":"Vill","year":"2024","journal-title":"J. Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26001176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26001176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:01:43Z","timestamp":1793739703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X26001176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":154,"alternative-id":["S0022510X26001176"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.125835","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Workshop report: Findings from the 2025 Italian SMAkers Educational Initiative on SMA management in Italy","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.125835","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"125835"}}